GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (BSP:S1YK34) » Definitions » Cyclically Adjusted Revenue per Share

Stryker (BSP:S1YK34) Cyclically Adjusted Revenue per Share : R$11.28 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Stryker Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Stryker's adjusted revenue per share for the three months ended in Mar. 2024 was R$3.390. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$11.28 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Stryker's average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Stryker was 23.30% per year. The lowest was 7.90% per year. And the median was 12.00% per year.

As of today (2024-05-24), Stryker's current stock price is R$85.60. Stryker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$11.28. Stryker's Cyclically Adjusted PS Ratio of today is 7.59.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stryker was 8.22. The lowest was 3.73. And the median was 6.22.


Stryker Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Stryker's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Cyclically Adjusted Revenue per Share Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 8.12 9.37 10.52 10.36

Stryker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.27 10.60 10.79 10.36 11.28

Competitive Comparison of Stryker's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Stryker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Stryker's Cyclically Adjusted PS Ratio falls into.



Stryker Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stryker's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.39/131.7762*131.7762
=3.390

Current CPI (Mar. 2024) = 131.7762.

Stryker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.690 100.560 0.904
201409 0.730 100.428 0.958
201412 0.903 99.070 1.201
201503 0.974 99.621 1.288
201506 0.993 100.684 1.300
201509 1.241 100.392 1.629
201512 1.393 99.792 1.839
201603 1.222 100.470 1.603
201606 1.284 101.688 1.664
201609 1.216 101.861 1.573
201612 1.397 101.863 1.807
201703 1.218 102.862 1.560
201706 1.307 103.349 1.667
201709 1.238 104.136 1.567
201712 1.501 104.011 1.902
201803 1.396 105.290 1.747
201806 1.648 106.317 2.043
201809 1.752 106.507 2.168
201812 1.940 105.998 2.412
201903 1.780 107.251 2.187
201906 1.854 108.070 2.261
201909 1.943 108.329 2.364
201912 2.230 108.420 2.710
202003 2.309 108.902 2.794
202006 1.910 108.767 2.314
202009 2.654 109.815 3.185
202012 2.876 109.897 3.449
202103 2.918 111.754 3.441
202106 2.824 114.631 3.246
202109 2.869 115.734 3.267
202112 3.477 117.630 3.895
202203 2.779 121.301 3.019
202206 2.967 125.017 3.127
202209 3.076 125.227 3.237
202212 3.570 125.222 3.757
202303 3.247 127.348 3.360
202306 3.158 128.729 3.233
202309 3.157 129.860 3.204
202312 3.713 129.419 3.781
202403 3.390 131.776 3.390

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Stryker  (BSP:S1YK34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Stryker's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=85.60/11.28
=7.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stryker was 8.22. The lowest was 3.73. And the median was 6.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Stryker Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Stryker's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (BSP:S1YK34) Business Description

Industry
Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Stryker (BSP:S1YK34) Headlines

No Headlines